A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS

University of Bergen Department of Clinical Science, Translational Hemato-Oncology group, Faculty of Medicine and Dentistry, Haukelands University Hospital, Bergen

Azienda Ospedaliera S Croce E Carle, Via Michele Coppino, Cuneo

Ospedale Policlinico San Martino, Genoa

University Medical Center Hamburg, Hamburg

Medizinische Hochschule Hannover,Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation,, Hanover

Azienda Ospedaliero-Universitaria di Parma, Parma

University of Iowa Hospitals and Clinics, Iowa City

Frankfurt Medizinische Klinik II, Hämatologie/Onkologie, Haus 33, 2. OG, Frankfurt

Ospedale Lecce - 'V Fazzi' U. O. Ematologia - P. O. Vito Fazz Piazza Muratore, IV piano Polo Oncologico, Lecce

The University of Texas M.D. Anderson Cancer Center, Houston

Universitätsklinikum Ulm, Ulm

Studienzentrale der Hämatologie/Onkologie III, Medizinische Klinik, Mannheim